Home › Stocks › BOLT › Changes

Who bought & sold BOLT (Q2 2026)

Funds holding (Q2 2026)24
New positions3
Added5
Reduced4
Exited3

As of Q2 2026, 24 institutional funds reported holding BOLT (Bolt Biotherapeutics): 3 opened new positions, 5 added, 4 trimmed and 3 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (3)

Fund Shares Value Weight
GEODE CAPITAL MANAGEMENT, LLC New 19.12K $73.62K —
NewEdge Advisors, LLC New 2.53K $9.74K —
Citigroup Inc New 41 $158 —

Added to positions (5)

Fund Shares Value Weight Change
Citadel Advisors 56.90K $219.08K — +46.79K sh (+462.9%)
Renaissance Technologies 98.62K $379.71K 0.0 +21.40K sh (+27.7%)
Tower Research Capital LLC (TRC) 1.71K $6.58K — +617 sh (+56.5%)
Shay Capital LLC 15.44K $59.44K 0.0 +533 sh (+3.6%)
SBI Securities Co., Ltd. 130 $501 — +120 sh (+1200.0%)

Reduced positions (4)

Fund Shares Value Weight Change
Nan Fung Group Holdings Ltd 5.00K $19.25K 0.0 -24.25K sh (-82.9%)
Geode Capital Management 19.12K $73.62K — -9.67K sh (-33.6%)
UBS Group AG 255 $982 — -532 sh (-67.6%)
Morgan Stanley 3.15K $12.11K — -44 sh (-1.4%)

Exited positions (3)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Pivotal bioVenture Partners Investment Advisor LLC Exited 42.58K $172.03K 0.1
SUSQUEHANNA INTERNATIONAL GROUP, LLP Exited 11.66K $47.09K —
Vanguard Global Advisers, LLC Exited 24 $97 —